Epidermal growth factor receptor (EGFR) activating mutations (muts) in the tyrosine kinase (TK) domain correlate with gefitinib response in chemorefractory non-small-cell lung cancer (NSCLC)

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Activating Mutations ◽

Faculty Opinions recommendation of Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1018878.217464 ◽

2004 ◽

Author(s):

Joachim Herz

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Activating Mutations ◽

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib

New England Journal of Medicine ◽

10.1056/nejmoa040938 ◽

2004 ◽

Vol 350 (21) ◽

pp. 2129-2139 ◽

Cited By ~ 7880

Author(s):

Thomas J. Lynch ◽

Daphne W. Bell ◽

Raffaella Sordella ◽

Sarada Gurubhagavatula ◽

Ross A. Okimoto ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Activating Mutations ◽

Faculty Opinions recommendation of Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1018878.219430 ◽

2004 ◽

Author(s):

Michael B Yaffe

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Activating Mutations ◽

Faculty Opinions recommendation of Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1018878.214468 ◽

2004 ◽

Author(s):

William Kaelin

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Activating Mutations ◽

4CPS-120 Erlotinib in non-small-cell lung cancer without epidermal growth factor receptor activating mutations

10.1136/ejhpharm-2019-eahpconf.269 ◽

2019 ◽

Author(s):

D Yáñez Feria ◽

IM Carrion Madroñal ◽

MT Garrido Martinez ◽

O Montero Pérez ◽

MD Santos Rubio

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Activating Mutations ◽

Faculty Opinions recommendation of Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1018878.257657 ◽

2004 ◽

Cited By ~ 1

Author(s):

Charles Brenner

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Activating Mutations ◽

Faculty Opinions recommendation of Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1018878.14725082 ◽

2011 ◽

Author(s):

Ruth Palmer

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Activating Mutations ◽

Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non-Small-Cell Lung Cancer to Gefitinib

Yearbook of Pulmonary Disease ◽

10.1016/s8756-3452(08)70091-4 ◽

2006 ◽

Vol 2006 ◽

pp. 110-113

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Activating Mutations ◽

529 The role of aromatase and epidermal growth factor receptor in non-small cell lung cancer

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(10)71330-6 ◽

2010 ◽

Vol 8 (5) ◽

pp. 135

Author(s):

I. Kritikou ◽

E. Giannopoulou ◽

A. Koutras ◽

K. Dimitropoulos ◽

H. Kalofonos

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

397 Epidermal Growth Factor Receptor (EGFR) Expression Levels Predict Cetuximab Activity in Non-small-cell Lung Cancer (NSCLC)

European Journal of Cancer ◽

10.1016/s0959-8049(12)72195-0 ◽

2012 ◽

Vol 48 ◽

pp. 121

Author(s):

C. Stroh ◽

E. Staub ◽

M. Friese-Hamim ◽

S. Störkel ◽

C. Amendt

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Small Cell Lung Cancer ◽

Growth Factor Receptor ◽

Small Cell ◽

Small Cell Lung ◽

Egfr Expression ◽